Suppr超能文献

特利加压素治疗肝肾综合征时导致皮肤坏死:来自印度北部的一例罕见病例报告

Terlipressin-Induced Skin Necrosis While Managing Hepatorenal Syndrome: A Rare Case Report From North India.

作者信息

Sudan Sourav, Chaudhary Sahil, Bethineedi Lakshmi Deepak, Kaur Navjot, Goyal Ninia

机构信息

Internal Medicine, Government Medical College Rajouri, Rajouri, IND.

Internal Medicine, Government Medical College Jammu, Jammu, IND.

出版信息

Cureus. 2023 Mar 31;15(3):e36980. doi: 10.7759/cureus.36980. eCollection 2023 Mar.

Abstract

Terlipressin is an analogue of vasopressin and is often used in the treatment of bleeding esophageal varices and also in the treatment of hepatorenal syndrome associated with liver cirrhosis. Although terlipressin is a safe drug, but it has been rarely associated with potentially serious adverse effects like ischemic necrosis of skin involving the abdominal skin, extremities, and scrotal skin. We present one such rare case where terlipressin-induced skin necrosis in bilateral lower extremities in a 48-year-old male while we were managing hepatorenal syndrome in the same.

摘要

特利加压素是血管加压素的类似物,常用于治疗食管静脉曲张出血以及与肝硬化相关的肝肾综合征。尽管特利加压素是一种安全的药物,但它很少与潜在的严重不良反应相关,如累及腹部皮肤、四肢和阴囊皮肤的皮肤缺血性坏死。我们报告了这样一例罕见病例,一名48岁男性在我们治疗其肝肾综合征时,特利加压素导致双侧下肢皮肤坏死。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3013/10149593/162ea7b03744/cureus-0015-00000036980-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验